Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-03-02 @ 10:04 PM
Study NCT ID:
NCT05234320
Status:
UNKNOWN
Last Update Posted:
2022-09-22
First Post:
2022-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers of the Novel Self-Administered Intranasal CG- SpikeDown Antiviral Drug
Sponsor:
Caregen Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-06
First Submit QC Date:
None
Study First Post Date:
2022-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-20
Last Update Post Date:
2022-09-22
Last Update Post Date Type:
ACTUAL